---
id: biomaterials-and-biofabrication
name: Biomaterials & Biofabrication
family: technological
tier: active
url: https://futuremap.talin.digital/e/biomaterials-and-biofabrication/
license: CC-BY-NC-4.0
---

# Biomaterials & Biofabrication

## Maturity
2/5 — Real commercial production at a marginal share of plastics, with capacity running well ahead of output.

Source: European Bioplastics / nova-Institute, Bioplastics Market Development Update 2024 (Dec 2024): 2.47 Mt capacity, 1.44 Mt actual production (58% utilisation), packaging 45%. The 2025 update puts bioplastics at ~0.5% of 431 Mt of plastics produced annually (2024)

## What it is
Materials grown or derived from biological processes — bio-based plastics, mycelium composites, bioprinted tissue and biomimetic structures.

## What it does
It offers substitution rather than efficiency: replacing a material whose production is the problem, instead of using less of it. That is a different and more durable route to reducing throughput.

## Common misconception
That bio-based means benign. Land use, water use and end-of-life behaviour vary enormously, and some bio-based plastics are neither compostable in practice nor recyclable in existing streams.

## Steepens
- Circular Economy and Materials Substitution (circular-economy-and-materials-substitution) — large
- Pollution and Waste Burden (pollution-and-waste-burden) — moderate
- Food System Transformation (food-system-transformation) — marginal
- The Built-Environment Deficit (the-built-environment-deficit) — moderate
- Nature Restoration (nature-restoration) — moderate

## What would change its gradient
- Cost parity with petrochemical equivalents
- End-of-life infrastructure that actually accepts them
- Land and water footprint, which bounds how far substitution can scale
